Toutouzas P et al. - The ENHANCE study failed in its primary endpoint, carotid intima–media thickness reduction, but has various methodological weaknesses that makes it very difficult to accept the American College of Cardiology statement that ezetimibe should be the last resort after trying all other available treatments.
See all
